-+ 0.00%
-+ 0.00%
-+ 0.00%

HALOZYME THERAPEUTICS INC - SKYE PLANS PHASE 2B TRIAL FOR NIMACIMAB IN MID-2026

Reuters·01/05/2026 12:00:03

Please log in to view news